REPL
Replimune Group Inc
Price:  
5.71 
USD
Volume:  
2,254,571.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-1663.8%
Upside

As of 2025-09-18, the Relative Valuation of Replimune Group Inc (REPL) is (89.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.71 USD, the upside of Replimune Group Inc based on Relative Valuation is -1663.8%.

The range of the Relative Valuation is (85.08) - (85.08) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 22.3x - 23.7x 23.0x
Forward P/E multiples 23.7x - 29.8x 26.8x
Fair Price (85.08) - (85.08) (89.30)
Upside -1590.0% - -1590.0% -1663.8%
5.71 USD
Stock Price
(89.30) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2025-09-08 -1.68
2025-09-05 -1.76
2025-09-04 -1.62
2025-09-03 -1.64
2025-09-02 -1.64
2025-08-29 -1.50
2025-08-28 -1.50
2025-08-27 -1.54
2025-08-26 -1.58
2025-08-25 -1.53
2025-08-22 -1.58
2025-08-21 -1.56
2025-08-20 -1.46
2025-08-19 -1.47
2025-08-18 -1.48
2025-08-15 -1.55
2025-08-14 -1.49
2025-08-13 -1.42
2025-08-12 -1.46
2025-08-11 -1.39
2025-08-08 -1.47
2025-08-07 -1.53
2025-08-06 -1.53
2025-08-05 -1.76
2025-08-04 -1.59
2025-08-01 -2.12
2025-07-31 -1.96
2025-07-30 -2.10
2025-07-29 -1.04
2025-07-28 -0.88
2025-07-25 -0.88
2025-07-24 -0.86
2025-07-23 -0.93
2025-07-22 -0.78
2025-07-21 -3.43
2025-07-18 -3.37
2025-07-17 -3.48
2025-07-16 -3.52
2025-07-15 -3.45
2025-07-14 -3.14
2025-07-11 -3.06
2025-07-10 -3.00
2025-07-09 -2.89
2025-07-08 -2.60
2025-07-07 -2.69
2025-07-03 -2.62
2025-07-02 -2.66
2025-07-01 -2.55
2025-06-30 -2.59
2025-06-27 -2.60